Cancer Immunotherapy

Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment
Jing Li, Robert L Ferris

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P220; DOI: 10.1186/2051-1426-2-S3-P220
Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
S Carolina Berger, Daniel Sommermeyer, Michael Hudecek, Michael Berger, Ashwini Balakrishnan, Paulina Paskiewicz, Paula Kosasih, Christoph Rader, Stanley Riddell

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P3; DOI: 10.1186/2051-1426-2-S3-P3
Discovery of novel immune checkpoint regulators in a comprehensive library of human extracellular proteins
Nathan A Sallee, Ernestine Lee, Andrew Rankin, Robert Halenbeck, Arthur Brace, Lewis T Williams, Brian Wong, W Michael Kavanaugh

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P142; DOI: 10.1186/2051-1426-2-S3-P142
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen, Peter Mohr

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 27; DOI: 10.1186/s40425-014-0027-z
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
G Cojocaru, G Rotman, O Levy, A Toporik, L Dassa, I Vaknin, S Sameah-Greenwald, I Barbiro, E Neria, Z Levine

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) I5; DOI: 10.1186/2051-1426-2-S2-I5
P58. Can T-cells predict response to intravesical BCG immunotherapy in high-risk non-invasive bladder cancer
S Jallad, P Thomas, M Newport, F Kern

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P32; DOI: 10.1186/2051-1426-2-S2-P32
DCVax^®- DIRECT: autologous activated dendritic cells for image guided intra-tumoral vaccination in patients with solid tumors - a phase I/II clinical trial in progress
Vivek Subbiah, Ravi Murthy, Chitra Hosing, Indresh Kaur, Gerald Falchook, Marnix Bosch

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P238; DOI: 10.1186/2051-1426-1-S1-P238
Synergistic effects of agonistic costimulatory antibodies adsorbed to amphiphilic poly(γ-glutamic acid) nanoparticles
Catja Freiburghaus, Sissela Broos, Linda C Sandin, Thomas H Tötterman, Takami Akagi, Mitsuru Akashi, Carl Borrebaeck, Peter Ellmark, Malin Lindstedt

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P128; DOI: 10.1186/2051-1426-1-S1-P128
Induction of antigen spread after sipuleucel-T treatment and its association with improved clinical outcome
Debraj GuhaThakurta, Li-Qun Fan, Tuyen Vu, Nadeem A Sheikh, James B Trager

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P101; DOI: 10.1186/2051-1426-1-S1-P101
Identification of novel immune checkpoints as targets for cancer immunotherapy
Galit Rotman, Ofer Levy, Amir Toporik, Gady Cojocaru, Liat Dassa, Iris Hecht, Ilan Vaknin, Anat Oren, Zohar Tiran, Nora Tarcic, Sergey Nemzer, Tania Pergam, Amit Novik, Shirley Sameah-Greenwald, Joseph R Podojil, Stephen D Miller, Judith Leitner, Peter Steinberger, Eyal Neria, Zurit Levine

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P135; DOI: 10.1186/2051-1426-1-S1-P135

Main menu

Cancer Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cancer Immunotherapy

Pages